Home Blog Page 140

Blog

Pharma Marketing Blog

Most popular

Drug Overdose Deaths in America at Crisis Level

Pharma Guy - May 12, 2016

We Do Hope Y’All Will Enter! Contests Guarantee ROI for Diabetes...

Pharma Guy - March 7, 2013

Adherence Programs: Start by Understanding Patients

Pharma Guy - January 20, 2009

YouTube Interruptus! Dear WhyInsulin: WHY the Dreadful LANTUS Safety Information Blue...

Pharma Guy - April 27, 2011

Behavioral Targeting: RJ vs JP

Pharma Guy - June 15, 2006

Use of Internet to Obtain Health Information Can Make You Depressed

Pharma Guy - March 16, 2010

Is DTC Bankrupting Pharma?

Pharma Guy - April 3, 2008

PharmaGuy’s Pharma Marketing Buzzword Glossary

Pharma Guy - April 7, 2016

This Ethics Guideline for Pharma CME Support is a Pile of...

Pharma Guy - October 12, 2012

Did Cephalon Pay James Mcmillen $101,650 to Help Promote Actiq for...

Pharma Guy - February 4, 2010

1...139140141...240 Page 140 of 240

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

Researcher analyzing genetic data for an ultra-rare disease alongside physicians, DNA imagery, and patient silhouettes representing rare disease awareness and patient identification.

How Do You Market a Disease That Doesn’t Officially Exist?

August 6, 2026

Healthcare professional reviewing a plain-language clinical trial summary with a patient, illustrating how transparent communication strengthens trust, patient engagement, and pharmaceutical marketing.

The Plain-Language Revolution: How Compliance Is Becoming a Marketing Advantage

August 5, 2026

Healthcare professional reviewing a personalized medication dosing plan, illustrating flexible dosing strategies that support patient persistence and individualized treatment.

Could Flexible Dosing Become Pharma’s Next Competitive Advantage?

August 4, 2026